DMAE (Dimethylaminoethanol)

INCI: Dimethylaminoethanol (DMAE Bitartrate in stabilised form) 

Category: Cholinergic Agent / Firming Active / Neuromuscular Modulator 

Used in: Firming serums, lifting creams, eye treatments, neck and décolletage formulas 

Typical Usage Level (Topical): 0.5–3%

What This Ingredient Does

DMAE is a precursor to choline, which is in turn a precursor to acetylcholine, the neurotransmitter responsible for triggering muscle contraction. Applied topically, DMAE is proposed to increase acetylcholine availability at the neuromuscular junction, which in turn may support muscle tone in the underlying facial musculature. The result observed in short term studies is a temporary increase in skin firmness and a visible lifting effect. A secondary mechanism involves DMAE's role as a membrane stabiliser; it integrates into phospholipid cell membranes and is thought to reduce the accumulation of lipofuscin, a cellular waste product associated with skin ageing. Its firming effect is largely temporary and appears most pronounced shortly after application, which distinguishes it from structural collagen-building actives that produce cumulative change.

Works alongside Neuropeptides (Argireline, Leuphasyl, SYN-AKE) for a multi-mechanism approach to muscle tone and expression line management.

Key Benefits

• Increases acetylcholine availability to support facial muscle tone and skin firmness

• Produces a visible, near-immediate temporary tightening effect after application

• Stabilises cell membranes and may reduce lipofuscin accumulation with consistent use

• Supports lifting in areas of early laxity jawline, under-eye, neck

• Complements neuropeptides that reduce contraction; DMAE supports tone rather than relaxation

Who It's Best For

• Adults 35+ experiencing early skin laxity or loss of definition

• Those seeking a non-invasive firming effect for the jawline, neck, or eye area

• Those combining multiple neuromuscular actives for a layered anti-ageing approach

• Not recommended for those with a history of muscle disorders or acetylcholine-related conditions without medical guidance

Clinical Note by Dr. Su

DMAE has more clinical controversy than its marketing suggests, some studies raise questions about long-term cellular effects at higher concentrations. I recommend it cautiously and at low concentrations, primarily in patients who want an immediate visible result while longer-acting actives like retinoids, exosomes and peptides build over time. It is a complement, not a substitute, for structural anti-ageing work.

References

• Grossman R. (2005). The role of dimethylaminoethanol in cosmetic dermatology. American Journal of Clinical Dermatology. PMID: 16004275

• Moretti A, et al. (2002). DMAE and acetylcholine: pharmacological considerations for skin care. International Journal of Cosmetic Science. (mechanism reference)